Impact Biomedical, Inc.(IBO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IBO Impact Biomedical, Inc.

盘前交易 10-01 04:23:58 EDT

5.60

+0.00

0.00%

最高5.75	最低5.48	成交量3,925
今开5.48	昨收5.60	日振幅4.82%
总市值4,792万	流通市值509.77万	总股本855.78万
成交额2.19万	换手率0.43%	流通股本91.03万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IBO","market":"US","secType":"STK","nameCN":"Impact Biomedical, Inc.","latestPrice":5.6,"timestamp":1790798400000,"preClose":5.6,"halted":0,"volume":3925,"delay":0,"changeRate":0,"floatShares":910305,"shares":8557812,"eps":0.08834,"marketStatus":"盘前交易","change":0,"latestTime":"10-01 04:23:58 EDT","open":5.48,"high":5.75,"low":5.48,"amount":21932.87488,"amplitude":0.048214,"askPrice":6.62,"askSize":100,"bidPrice":2.24,"bidSize":200,"shortable":3,"etf":0,"ttmEps":0.08834,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1721361600000,"exchange":"AMEX","adjPreClose":5.6,"postHourTrading":{"tag":"盘后","latestPrice":5.6,"preClose":5.6,"latestTime":"18:28 EDT","volume":29,"amount":159.54,"timestamp":1790807310251,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.19087903372431808,"impliedVol":0.2695,"impliedVolPercentile":1},"requestUrl":"/m/hq/s/IBO","defaultTab":"news","newsList":[{"id":"1130620347","title":"新闻稿：DSS, Inc. 就Impact Biomedical与Zoar Limited拟议业务合并提交F-4表格声明","url":"https://stock-news.laohu8.com/highlight/detail?id=1130620347","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130620347?lang=zh_cn&edition=full","pubTime":"2026-09-16 21:30","pubTimestamp":1789565408,"startTime":"0","endTime":"0","summary":"纽约州罗切斯特，2026年9月16日——DSS, Inc.今日宣布，Zoar Limited已就先前披露的涉及Impact Biomedical Inc.，Zoar及若干关联方的拟议业务合并，向美国证券交易委员会提交了F-4表格注册声明。DSS是Impact Biomedical的重要股东，此次申报标志着Impact与Zoar拟议合并进程中的关键一步。注册声明包含Impact的初步委托书声明及Zoar与拟议交易相关的招股说明书。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","DSS","BK4007","BK4087","IBO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134255152","title":"更正——Impact Biomedical Inc（NYSE：IBO）宣布按1：12.62比例进行股份合并，以推进与Zoar Limited（前身为DR Ashleys Limited）的并购完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1134255152","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134255152?lang=zh_cn&edition=full","pubTime":"2026-09-15 09:27","pubTimestamp":1789435635,"startTime":"0","endTime":"0","summary":"更正——Impact Biomedical Inc（NYSE：IBO）今日宣布，将实施一项1：12.62的反向股份拆分计划，此举旨在推进其与Zoar Limited（前身为DR Ashleys Limited）并购交易的最终完成。该股份合并方案的落地，标志着公司在整合道路上迈出了关键一步，为后续交易交割铺平了道路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IBO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127360673","title":"Impact Biomedical（纽交所美国：IBO）宣布实施1比12.62反向拆股 推进与Zoar Ltd.（原DR. Ashley's Ltd.）合并交割","url":"https://stock-news.laohu8.com/highlight/detail?id=1127360673","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127360673?lang=zh_cn&edition=full","pubTime":"2026-09-12 04:06","pubTimestamp":1789157170,"startTime":"0","endTime":"0","summary":"Impact Biomedical, Inc.今日对外公告，公司将执行一项1比12.62的反向股票拆分方案。此举旨在加速推进与Zoar Ltd.的并购交易进程，确保交易最终顺利收官。此次Impact Biomedical所披露的拆分比率并非整数，折射出各方在谈判桌上达成的精确计算与现实考量。通过此番资本运作，Impact Biomedical希望能为合并交易铺平道路，同时进一步优化其股本结构。根据公告内容，该公司显然正在采取实质性行动，以完成此前公布的战略整合计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IBO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.impactbiomedinc.com","stockEarnings":[{"period":"1week","weight":-0.1554},{"period":"1month","weight":-0.0377},{"period":"3month","weight":-0.0599},{"period":"6month","weight":-0.2487},{"period":"1year","weight":-0.3325},{"period":"ytd","weight":-0.1213}],"compareEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":-0.0058},{"period":"3month","weight":0.024},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.1448},{"period":"ytd","weight":0.1184}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Impact BioMedical Inc.是一家内华达州公司，成立于2018年10月16日。该公司是DSS, Inc.的子公司。该公司致力于发现、验证并申请专利独特的科学技术，并通过许可、合作开发、合资企业及其他合作关系，与外部合作伙伴共同开发人类健康领域的新产品。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.006089},{"month":2,"riseRate":0,"avgChangeRate":-0.00359},{"month":3,"riseRate":0.2,"avgChangeRate":0.024966},{"month":4,"riseRate":0,"avgChangeRate":-0.000241},{"month":5,"riseRate":0,"avgChangeRate":0},{"month":6,"riseRate":0,"avgChangeRate":0},{"month":7,"riseRate":0,"avgChangeRate":0},{"month":8,"riseRate":0,"avgChangeRate":0},{"month":9,"riseRate":0,"avgChangeRate":0},{"month":10,"riseRate":0.166667,"avgChangeRate":0.051754},{"month":11,"riseRate":0,"avgChangeRate":-0.004418},{"month":12,"riseRate":0,"avgChangeRate":-0.004813}],"exchange":"AMEX","name":"Impact Biomedical, Inc.","nameEN":"Impact Biomedical, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Impact Biomedical, Inc.(IBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Impact Biomedical, Inc.(IBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Impact Biomedical, Inc.,IBO,Impact Biomedical, Inc.股票,Impact Biomedical, Inc.股票老虎,Impact Biomedical, Inc.股票老虎国际,Impact Biomedical, Inc.行情,Impact Biomedical, Inc.股票行情,Impact Biomedical, Inc.股价,Impact Biomedical, Inc.股市,Impact Biomedical, Inc.股票价格,Impact Biomedical, Inc.股票交易,Impact Biomedical, Inc.股票购买,Impact Biomedical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Impact Biomedical, Inc.(IBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Impact Biomedical, Inc.(IBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}